LTA Antikörper (AA 45-59)
Kurzübersicht für LTA Antikörper (AA 45-59) (ABIN2625001)
Target
Alle LTA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 45-59
-
Aufreinigung
- Immunogen affinity purified
-
Immunogen
- A synthetic peptide corresponding to a sequence at the N-terminus of human TNF beta(45-59aa AQTARQHPKMHLAHS).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Rekonstitution
- Distilled water
-
Konzentration
- Lot specific
-
Buffer
- Contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2 HPO4, 0.05 mg Thimerosal, 0.05 mg sodium azide per 100 μg antibody.
-
Konservierungsmittel
- Sodium azide, Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Handhabung
- Avoid freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- At -20°C for 1 year. After reconstitution, at 4°C for 1 month. It can also be aliquotted and stored frozen at -20°C for a longer time.Avoid freeze-thaw cycles.
-
-
- LTA (Lymphotoxin-alpha (LTA))
-
Andere Bezeichnung
- LTA / TNF beta
-
Substanzklasse
- Chemical
-
Hintergrund
-
Name/Gene ID: LTA
Family: TNF
Synonyms: LTA, Lymphotoxin-alpha, LT-alpha, TNFSF1, TNF-beta, TNFB, Tumor necrosis factor beta, LT, TNF Beta -
Gen-ID
- 4049
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Target
-